Jane Chen

In this discussion, Jane Chen, Director of Commercial Analytics for Women’s Cancer at Novartis, shares her expertise on the hurdles in identifying patient groups with rare diseases. She emphasizes the impact of HIPAA regulations on data privacy and the challenges posed by fragmented data sources. Jane also highlights the innovative potential of generative AI in transforming patient experiences, insisting on the importance of integrating commercial data to improve healthcare workflows. Her insights shine a light on the evolving landscape of life sciences analytics.